| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $412.5M | +1446.0% |
| R&D Expense | $208.6M | +4.4% |
| SG&A Expense | $73.4M | +72.4% |
| Operating Income | $130.5M | +160.5% |
| Pre-tax Income | $135.2M | +163.7% |
| Income Tax | $10.9M | +2211.0% |
| Net Income | $124.3M | +158.7% |
| EPS (Basic) | $1.91 | +146.5% |
| EPS (Diluted) | $1.90 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $400.9M | +98.6% |
| Short-term Investments | $91.3M | +80.0% |
| Accounts Receivable | $33.4M | +113.9% |
| Current Assets | $544.7M | +89.0% |
| Total Assets | $648.7M | +66.7% |
| Current Liabilities | $95.6M | +33.1% |
| Total Liabilities | $155.8M | +11.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $144.1M | +174.9% |
| Capital Expenditures | $8.2M | -34.3% |
| Investing Cash Flow | -$53.8M | -137.2% |
| Financing Cash Flow | $108.6M | +1255.4% |
| Free Cash Flow | $136.0M | +166.4% |
| +141.2% |
| Stockholders' Equity |
| $493.0M |
| +97.9% |